产品编号 | CFN60056 | |
CAS编号 | 915019-65-7 | |
分子式 = 分子量 | C30H23N5O = 469.55 | |
产品纯度 | >=98% | |
物理属性 | Powder | |
化合物类型 | Alkaloids | |
植物来源 | ||
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 |
产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
Dactolisib (BEZ235) | CFN60056 | 915019-65-7 | 1mg | QQ客服:2159513211 |
Dactolisib (BEZ235) | CFN60056 | 915019-65-7 | 5mg | QQ客服:2159513211 |
Dactolisib (BEZ235) | CFN60056 | 915019-65-7 | 10mg | QQ客服:2159513211 |
Dactolisib (BEZ235) | CFN60056 | 915019-65-7 | 20mg | QQ客服:2159513211 |
Description: | Dactolisib (BEZ235, NVP-BEZ235) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell. Dactolisib induces autophagy and suppresses HIV-1 replication. |
Targets: | PI3K | mTOR | ATR | Autophagy | HIV |
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1297 mL | 10.6485 mL | 21.297 mL | 42.594 mL | 53.2425 mL |
5 mM | 0.4259 mL | 2.1297 mL | 4.2594 mL | 8.5188 mL | 10.6485 mL |
10 mM | 0.213 mL | 1.0648 mL | 2.1297 mL | 4.2594 mL | 5.3242 mL |
50 mM | 0.0426 mL | 0.213 mL | 0.4259 mL | 0.8519 mL | 1.0648 mL |
100 mM | 0.0213 mL | 0.1065 mL | 0.213 mL | 0.4259 mL | 0.5324 mL |
产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
L-4-羟基异亮氨酸; L-4-Hydroxyisoleucine | CFN90214 | 6001-78-8 | C6H13NO3 = 147.17 | 20mg | QQ客服:2159513211 |
4,4'-二羟基-2',6'-二甲氧基查耳酮 ; 2'-O-Methylhelichrysetin | CFN97920 | 123316-64-3 | C17H16O5 = 300.3 | 5mg | QQ客服:3257982914 |
20(R)-原人参三醇; 20(R)-Protopanaxatriol | CFN99980 | 1453-93-6 | C30H52O4 = 476.73 | 20mg | QQ客服:2159513211 |
4,9-二羟基-alpha-拉帕醌; 4,9-Dihydroxy-alpha-lapachone | CFN98947 | 56473-67-7 | C15H14O5 = 274.3 | 5mg | QQ客服:3257982914 |